Head-to-head comparisons built from published trial data and aggregated user reviews.
Ro and Hims both prescribe brand GLP-1s, but they score very differently. A side-by-side on real all-in cost, insurance, medications offered, and our methodology scores (Ro 7.0 vs Hims 5.9).
Read the guide →Compounded semaglutide and tirzepatide cost less, but what does the evidence say about whether they work and whether they're safe? The trial data, the FDA's documented concerns, and the 2026 legal picture.
Read the guide →What the clinical trials really show for Wegovy (semaglutide) and Zepbound (tirzepatide): average weight loss by dose, the head-to-head data, and why real-world results come in lower.
Read the guide →Efficacy data from published trials, side-effect rates, and real monthly costs with and without insurance: Wegovy (semaglutide) vs. Zepbound (tirzepatide), compared on the evidence.
Read the guide →One plain-English email a month: new study findings, price changes, and safety updates. No spam, ever.